Zur Suchmaske

US tax reform: Implications for pharma and life sciences

In December 2017, the United States enacted the most comprehensive tax reform in more than 30 years. For the pharmaceutical and life sciences sector, the changes will impact both US and non-US headquartered companies doing business in the United States.

Themen

Weiterlesen mit einem PwC Plus-Abonnement

  • qualitätsgesicherte Quellen
  • tägliche Updates
  • vollständige Filterfunktion von Artikeln
  • Verteilung via anpassbarem Alert

Jetzt 30 Tage kostenlos testen

Für den kostenfreien PwC Plus-Account registrieren

Loggen Sie sich ein, um den Artikel zu sehen

Mehr Informationen über PwC Plus

Zur Suchmaske
Zum Anfang
FAQ/Feedback

© 2017 - 2024 PwC. All rights reserved. PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Please see www.pwc.com/structure for further details.

This website contains copyright material of the IFRS® Foundation in respect of which all rights are reserved. Reproduced by PwC with the permission of the IFRS Foundation. No permission granted to third parties to reproduce or distribute. For full access to IFRS Standards and the work of the IFRS Foundation please visit www.ifrs.org.